🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial investigates the efficacy and safety of brodalumab against guselk...
Status
Terminated
Location
LEO Pharma Investigational Site
Start Date
2020-12-17
Trial ID
NCT04533737
Treatments Being Tested
The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monito...
Status
Recruiting
Location
University of California, San Diego
Start Date
2013-11
Trial ID
NCT02103361
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2014-11-26
Trial ID
NCT02207231
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of ustekinumab and CN...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01645280
It is a multicenter randomized, double-blinded, parallel, positive-controll...
Status
Recruiting
Location
Jining No.1 People's Hospital
Start Date
2026-06-15
Trial ID
NCT07511647
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2014-11-03
Trial ID
NCT02207244
Treatments Being Tested
"Guselkumab (Tremfya®) is a fully human monoclonal antibody that selectivel...
Status
Recruiting
Location
CHU de Nice
Start Date
2025-10-16
Trial ID
NCT07430319
Treatments Being Tested